Skip to main content
. 2015 Jun 18;26(9):1808–1812. doi: 10.1093/annonc/mdv266

Figure 2.

Figure 2.

Two possible sets of predefined combinations of agents A and B to be explored in a dose-escalation trial using the 3 + 3; combinations outside the dark gray (orange online) and black (blue online) lines are not tested.